Polymer-based non-viral gene delivery as a concept for the treatment of cancer

Anna Halama, Michał Kuliński, Tadeusz Librowski, Stanisław Lochyński

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNAfrom the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.

Original languageEnglish
Pages (from-to)993-999
Number of pages7
JournalPharmacological Reports
Volume61
Issue number6
DOIs
Publication statusPublished - 1 Jan 2009
Externally publishedYes

Fingerprint

Genetic Therapy
Polymers
Genes
Neoplasms
Transfection
Therapeutics
Ligands
Gene Expression
Costs and Cost Analysis

Keywords

  • Cancer
  • Gene delivery
  • Polymers
  • Polyplexes
  • Synthetic vectors

ASJC Scopus subject areas

  • Pharmacology

Cite this

Polymer-based non-viral gene delivery as a concept for the treatment of cancer. / Halama, Anna; Kuliński, Michał; Librowski, Tadeusz; Lochyński, Stanisław.

In: Pharmacological Reports, Vol. 61, No. 6, 01.01.2009, p. 993-999.

Research output: Contribution to journalReview article

Halama, Anna ; Kuliński, Michał ; Librowski, Tadeusz ; Lochyński, Stanisław. / Polymer-based non-viral gene delivery as a concept for the treatment of cancer. In: Pharmacological Reports. 2009 ; Vol. 61, No. 6. pp. 993-999.
@article{2c3b2e02eade47218193fda34430ff89,
title = "Polymer-based non-viral gene delivery as a concept for the treatment of cancer",
abstract = "Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNAfrom the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.",
keywords = "Cancer, Gene delivery, Polymers, Polyplexes, Synthetic vectors",
author = "Anna Halama and Michał Kuliński and Tadeusz Librowski and Stanisław Lochyński",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/S1734-1140(09)70160-4",
language = "English",
volume = "61",
pages = "993--999",
journal = "Pharmacological Reports",
issn = "1734-1140",
publisher = "Polish Academy of Sciences Publishing House",
number = "6",

}

TY - JOUR

T1 - Polymer-based non-viral gene delivery as a concept for the treatment of cancer

AU - Halama, Anna

AU - Kuliński, Michał

AU - Librowski, Tadeusz

AU - Lochyński, Stanisław

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNAfrom the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.

AB - Gene therapy has become a promising technique for the treatment of cancer. Nevertheless, the success of gene therapy depends on the effectiveness of the vector. The challenge of a gene carrier is to deliver exogenous DNAfrom the site of administration into the nucleus of the appropriate target cell. Polymer-based vectors are biologically safe, have low production costs and are efficient tools for gene therapy. Although non-degradable polyplexes exhibit high gene expression levels, their application potential is limited due to their inability to be effectively eliminated, which results in cytotoxicity. The development of biodegradable polymers has allowed for high levels of transfection without cytotoxicity. For site-specific targeting of polyplexes, further modifications, such as incorporation of ligands, can be performed. Most expectations have been addressed to polyplexes architecture according it dynamic response with the microenvironment.

KW - Cancer

KW - Gene delivery

KW - Polymers

KW - Polyplexes

KW - Synthetic vectors

UR - http://www.scopus.com/inward/record.url?scp=76049088849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76049088849&partnerID=8YFLogxK

U2 - 10.1016/S1734-1140(09)70160-4

DO - 10.1016/S1734-1140(09)70160-4

M3 - Review article

C2 - 20081233

AN - SCOPUS:76049088849

VL - 61

SP - 993

EP - 999

JO - Pharmacological Reports

JF - Pharmacological Reports

SN - 1734-1140

IS - 6

ER -